Clinical Trial Update: Intratumoral Administration of L19IL2/L19TNF [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intratumoral L19IL2/L19TNF in malignant melanoma (skin) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• L19IL2/L19TNF

Snippet

Sponsor: Philogen S.p.A. | Conditions: Malignant Melanoma, Skin | Phase 2 | Status: COMPLETED